- Home
- UNCY vs FMY Comparison
UNCY vs FMY Comparison
Compare UNCY & FMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNCY
- FMY
- Stock Information
- Founded
- UNCY 2016
- FMY 2005
- Country
- UNCY United States
- FMY United States
- Employees
- UNCY N/A
- FMY N/A
- Industry
- UNCY Biotechnology: Pharmaceutical Preparations
- FMY Finance/Investors Services
- Sector
- UNCY Health Care
- FMY Finance
- Exchange
- UNCY Nasdaq
- FMY Nasdaq
- Market Cap
- UNCY 58.7M
- FMY 50.9M
- IPO Year
- UNCY 2021
- FMY N/A
- Fundamental
- Price
- UNCY $0.62
- FMY $12.10
- Analyst Decision
- UNCY Strong Buy
- FMY
- Analyst Count
- UNCY 4
- FMY 0
- Target Price
- UNCY $5.50
- FMY N/A
- AVG Volume (30 Days)
- UNCY 1.0M
- FMY 10.1K
- Earning Date
- UNCY 03-27-2025
- FMY 01-01-0001
- Dividend Yield
- UNCY N/A
- FMY 6.98%
- EPS Growth
- UNCY N/A
- FMY N/A
- EPS
- UNCY N/A
- FMY N/A
- Revenue
- UNCY N/A
- FMY N/A
- Revenue This Year
- UNCY N/A
- FMY N/A
- Revenue Next Year
- UNCY N/A
- FMY N/A
- P/E Ratio
- UNCY N/A
- FMY N/A
- Revenue Growth
- UNCY N/A
- FMY N/A
- 52 Week Low
- UNCY $0.20
- FMY $10.71
- 52 Week High
- UNCY $1.80
- FMY $12.17
- Technical
- Relative Strength Index (RSI)
- UNCY 51.79
- FMY 52.99
- Support Level
- UNCY $0.57
- FMY $12.01
- Resistance Level
- UNCY $0.65
- FMY $12.16
- Average True Range (ATR)
- UNCY 0.05
- FMY 0.11
- MACD
- UNCY 0.01
- FMY -0.00
- Stochastic Oscillator
- UNCY 76.36
- FMY 59.79
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury.
About FMY First Trust Motgage Income Fund of Beneficial Interest
First Trust Mortgage Income Fund is a United States based diversified, closed-end management investment company. The fund's primary investment objective is to seek a high level of current income. Its secondary investment objective is to preserve capital. The fund pursues its objectives by investing predominantly in mortgage-backed securities representing part ownership in a pool of either residential or commercial mortgage loans that, in the opinion of the Fund's investment advisor, offer an attractive combination of credit quality, yield and maturity.